5 unchanged sentences
Additional risks not currently known or currently material to us may also harm our business.
−Removed: We may not be able to maintain compliance with the continued listing requirements of The Nasdaq Capital Market.
−Removed: To maintain continued listing on The Nasdaq Capital Market, we must satisfy minimum financial and other requirements.
−Removed: Nasdaq Listing Rule 5550(a)(2) requires a minimum bid price of at least $1.00 per share, and Nasdaq Listing Rule 5810(c)(3)(A) provides that a failure to meet the minimum bid price requirement exists if the deficiency continues for a period of 30 consecutive business days.
−Removed: Although the Company is currently in compliance with this requirement, there can be no assurance that we will be able to maintain compliance.
−Removed: We have in the past effected reverse stock splits of our Common Stock in order to regain or maintain compliance with this requirement (most recently on July 5, 2024).
−Removed: Such a delisting would have an adverse effect on the market liquidity of our securities, decrease the market price of our securities, result in the potential loss of confidence by investors, suppliers, customers and employees and fewer business development opportunities, and adversely affect our ability to obtain financing for the continuation of our operations.
−Removed: We actively monitor our minimum bid price and will consider any and all options available to us to maintain compliance with Nasdaq Listing Rule 5550(a)(2).
−Removed: Changes in U.S.
−Removed: and international trade policies may adversely impact our business and operating results.
−Removed: From time to time, proposals are made to significantly change existing trade agreements and relationships between the U.S.
−Removed: and other countries.
−Removed: In recent years, the U.S.
−Removed: government has implemented substantial changes to U.S.
−Removed: trade policies, including import restrictions, increased import tariffs and changes in U.S.
−Removed: participation in multilateral trade agreements.
−Removed: Because some of our vendors, manufactures and suppliers are located in foreign countries, we are exposed to the possibility of product supply disruption and increased costs in the event of changes in the policies, laws, rules and regulations of the United States or foreign governments, as well as political unrest or unstable economic conditions in foreign countries.
−Removed: government has adopted a new approach to trade policy and, in some cases, entered into new trade agreements.
−Removed: Our supply may in the future be subject to increased import tariffs, which could increase our manufacturing costs and could make our products, if successfully developed and approved, less competitive than those of our competitors whose inputs are not subject to such tariffs.
−Removed: We may otherwise experience supply disruptions or delays, and our suppliers may not continue to provide us with clinical supply in our required quantities, to our required specifications and quality levels or at attractive prices.
−Removed: Such disruption could have adverse effects on the development of our product candidates and our business operations.
+Added: Future financing may be obtained through, and future development efforts may be paid for by, the issuance of debt or equity, which may have an adverse effect on our stockholders or may otherwise adversely affect our business.
+Added: If we raise funds through the issuance of debt or equity, any debt securities or preferred stock issued will have rights, preferences and privileges senior to those of holders of Common Stock in the event of a liquidation.
+Added: In such event, there is a possibility that once all senior claims are settled, there may be no assets remaining to pay out to the holders of Common Stock.
+Added: The terms of debt securities may also impose restrictions on our operations, which may include limiting our ability to incur additional indebtedness, to pay dividends on or repurchase our capital stock, or to make certain acquisitions or investments.
+Added: In addition, we may be subject to covenants requiring us to satisfy certain financial tests and ratios, and our ability to satisfy such covenants may be affected by events outside of our control.
+Added: For example, in April 2026, we established an At The Market Agreement (the " Sales Agreement ") with H.C.
+Added: Wainwright & Co., LLC (" HCW ”) pursuant to which we may offer and sell shares of Common Stock having an aggregate offering price of up to $6,360,000 from time to time through HCW, acting as sales agent, at prevailing market prices pursuant to one or more “at the market” offerings.
+Added: As of the date of this filing, we have $6,360,000 million of Common Stock remaining available for sale under the Sales Agreement.
+Added: If we raise funds through the issuance of additional equity, whether through private placements or public offerings, which we have done in the past, including through one or more “at the market” offerings under the Sales Agreement, such issuances would dilute current stockholders’ ownership in us, perhaps substantially.
+Added: The issuance of a significant amount of shares of Common Stock could cause the market price of Common Stock to decline or become highly volatile.
UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
4 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.